VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 134 filers reported holding VIKING THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $283 | -77.7% | 25,528 | -67.4% | 0.03% | -71.1% |
Q2 2023 | $1,268 | -97.2% | 78,229 | +361.8% | 0.10% | +2325.0% |
Q3 2022 | $46,000 | -20.7% | 16,941 | +34.1% | 0.00% | -33.3% |
Q4 2021 | $58,000 | -57.7% | 12,633 | -44.9% | 0.01% | -53.8% |
Q2 2021 | $137,000 | -34.4% | 22,929 | -38.3% | 0.01% | -43.5% |
Q4 2020 | $209,000 | +127.2% | 37,152 | +191.1% | 0.02% | +109.1% |
Q2 2020 | $92,000 | +10.8% | 12,761 | +5.7% | 0.01% | +83.3% |
Q3 2019 | $83,000 | -50.6% | 12,071 | -40.3% | 0.01% | -40.0% |
Q2 2019 | $168,000 | -89.7% | 20,236 | -87.6% | 0.01% | -89.1% |
Q1 2019 | $1,628,000 | +1124.1% | 163,782 | +844.3% | 0.09% | +1214.3% |
Q4 2018 | $133,000 | -71.8% | 17,344 | -35.9% | 0.01% | -75.9% |
Q3 2018 | $472,000 | -11.9% | 27,073 | -52.1% | 0.03% | +20.8% |
Q2 2018 | $536,000 | +665.7% | 56,533 | +54.5% | 0.02% | +700.0% |
Q3 2017 | $70,000 | – | 36,588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |